Strategic Advisory
Aligning Science with Commercial Strategy to Accelerate Value Creation
Our strategic advisory service helps leaders in emerging biotech companies make confident, data-driven decisions that align science with a strong commercial proposition to attract partners, investors, and long-term value.


What We Do
Our biotech strategic advisory services are designed to help early-stage innovators establish credibility and position themselves for successful fundraising, partnership, and long-term growth. Whether you’re advancing a lead program or building a pipeline, we help ensure that your scientific story is matched by a commercially compelling case.
We serve as an extension of your leadership team, providing clear guidance, industry expertise, and actionable deliverables that resonate with strategic partners and investors.
Our capabilities include:

Opportunity Prioritization
Make focused, high-impact decisions about where to play and how to win.
We help you identify and evaluate your most commercially compelling use cases across indications and modalities. Our strategic frameworks integrate unmet need, competitive intensity, clinical development feasibility, and payer landscape to guide portfolio and pipeline investment decisions.
Value Proposition Development
Translate scientific potential into a story that excites investors and partners.
We work with you to define and articulate a differentiated value proposition that clearly explains the “so what?” of your innovation, rooted in data and grounded in market insight.
Target Product Profile (TPP) Optimization
Future-proof your product strategy by aligning clinical goals with commercial reality.
We develop or refine your TPPs to reflect meaningful clinical and commercial endpoints that resonate with payers, regulators, and strategic partners—while staying flexible for development-stage evolution.
Commercial Landscape & Competitive Assessment
Understand where you stand—and how to stand out.
We map the competitive and emerging landscape, identifying key threats, differentiators, and trends that could shape your program’s positioning over time.
Market Sizing and Revenue Potential
Quantify your opportunity—and communicate it credibly.
We build realistic TAM/SAM/SOM models tailored to your stage of development and investor needs, providing credible estimates rooted in epidemiology, patient segmentation, treatment pathways, and pricing analogs.
Commercial-Ready Clinical Development Strategy
Design trials today that support commercialization tomorrow.
We partner with clinical and regulatory teams to ensure your trials are built for market impact—from endpoint relevance to inclusion criteria to label expansion potential.
Investor & Partner Readiness
Stand out in a crowded field with a cohesive, compelling story.
We help you pull it all together in a way that makes your science investible and your strategy credible. Whether you’re going to JPM, pitching to VCs, or engaging pharma, we’ll help you make the right impression.